The Periodic Safety Update Report (PSUR) is a regulatory document regularly submitted by marketing authorisation holders.
It provides an updated assessment of a medicine’s safety profile, including reported adverse events and corrective actions taken.
PSUR enables health authorities to maintain continuous surveillance and reassess the benefit-risk balance of treatments.
